肌骨超声介入下复方倍他米松注射治疗与放射式冲击波治疗对肱二头肌长头腱鞘炎的临床疗效  

Clinical efficacy of musculoskeletal ultrasound-guided compound betamethasone injection therapy and radial shock-wave therapy on tenosynovitis of the long head of the biceps brachii

作　　者：程斯佳 王兴滨 CHENG Si-jia;WANG Xing-bin(Benxi Central Hospital,Benxi 117000,China)

机构地区：[1]本溪市中心医院,117000

出　　处：《中国现代药物应用》2023年第11期94-97,共4页Chinese Journal of Modern Drug Application

摘　　要：目的 研究肱二头肌长头腱鞘炎患者应用肌骨超声介入下复方倍他米松注射治疗与放射式冲击波治疗的效果。方法 74例肱二头肌长头腱鞘炎患者,根据电脑随机方式分为参照组和实验组,各37例。参照组采用放射式冲击波治疗,实验组采用肌骨超声介入下复方倍他米松注射治疗。对比两组治疗效果,治疗后不同时间的视觉模拟评分法(VAS)评分及主动关节活动度(AROM),治疗前后日常生活活动能力量表(ADL)评分。结果 实验组有效率94.59%高于参照组的75.68%,差异具有统计学意义(P<0.05)。治疗后1、3、5周,实验组VAS评分分别为(3.52±1.43)、(2.13±0.23)、(1.36±0.43)分,均低于参照组的(4.63±1.24)、(3.32±0.45)、(2.03±0.31)分,差异具有统计学意义(P<0.05)。治疗后1、3、5周,实验组AROM分别为(132.53±7.43)、(141.58±7.19)、(149.67±7.68)°,均大于参照组的(112.36±7.85)、(128.64±7.46)、(132.96±7.53)°,差异具有统计学意义(P<0.05)。治疗前,两组ADL评分对比,差异无统计学意义(P>0.05);治疗后,实验组ADL评分(86.94±2.51)分高于参照组的(74.95±2.64)分,差异具有统计学意义(P<0.05)。结论 肌骨超声介入下复方倍他米松注射治疗能够提升肱二头肌长头腱鞘炎的治疗效果,减少对患者的影响,缓解疼痛,改善关节活动度和生活质量,值得推广和使用。Objective To study the effect of musculoskeletal ultrasound-guided compound betamethasone injection therapy and radial shock-wave therapy on tenosynovitis of the long head of the biceps brachii.Methods A total of 74 patients with tenosynovitis of the long head of the biceps brachii were randomly divided into the reference group and the experimental group,with 37 cases in each group.The reference group received radial shock-wave therapy,and the experimental group received musculoskeletal ultrasound-guided compound betamethasone injection therapy.Both groups were compared in terms of therapeutic effect,visual analogue scale(VAS)score,active range of motion(AROM)score at different time after treatment,and activities of daily living(ADL)score before and after treatment.Results The effective rate of 94.59%in the experimental group was higher than that of 75.68%in the reference group,and the difference was statistically significant(P<0.05).At 1,3 and 5 weeks after treatment,VAS scores of the experimental group were(3.52±1.43),(2.13±0.23)and(1.36±0.43)points,which were lower than those of(4.63±1.24),(3.32±0.45)and(2.03±0.31)points of the control group,and the differences were statistically significant(P<0.05).At 1,3 and 5 weeks after treatment,AROM were(132.53±7.43),(141.58±7.19)and(149.67±7.68)°in the experimental group,which were greater than those of(112.36±7.85),(128.64±7.46)and(132.96±7.53)°in the reference group,and the differences were statistically significant(P<0.05).Before treatment,there was no statistically significant difference in ADL score between the two groups(P>0.05).After treatment,the ADL score of(86.94±2.51)points in the experimental group was higher than that of(74.95±2.64)points in the reference group,and the difference was statistically significant(P<0.05).Conclusion Musculoskeletal ultrasound-guided compound betamethasone injection therapy can improve the therapeutic effect of tenosynovitis of the long head of the biceps brachii,reduce the impact on patients,relieve pain,improve

关 键 词：肌骨超声介入 复方倍他米松 放射式冲击波 肱二头肌长头腱鞘炎 

分 类 号：R686.1[医药卫生—骨科学]